|
Symbol |
Object Name |
Qualifiers
|
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G
|
ABCB1
|
ATP binding cassette subfamily B member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21325069 |
|
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
|
|
G
|
ABCG2
|
ATP binding cassette subfamily G member 2 (JR blood group)
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21625222 |
|
NCBI chr 7:36,458,110...36,599,753
|
|
G
|
ALK
|
ALK receptor tyrosine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22474449 |
|
NCBI chr14:77,632,809...78,408,307
|
|
G
|
B2M
|
beta-2-microglobulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7688627 |
|
NCBI chr26:38,331,818...38,338,785
Ensembl chr26:38,331,442...38,338,809
|
|
G
|
BCAS2
|
BCAS2 pre-mRNA processing factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27356265 |
|
NCBI chr20:19,084,908...19,099,204
Ensembl chr20:19,084,954...19,099,590
|
|
G
|
BCL2
|
BCL2 apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
|
|
G
|
BCL6
|
BCL6 transcription repressor
|
disease_progression
|
ISO
|
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region
|
RGD |
PMID:11821949 PMID:15701085 |
RGD:11530023 RGD:1600111 |
NCBI chr15:81,997,659...82,022,059
Ensembl chr15:81,998,545...82,009,946
|
|
G
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
|
|
NCBI chr21:109,495,525...109,690,261
|
|
G
|
BRCA2
|
BRCA2 DNA repair associated
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:9150172 PMID:18489799 PMID:20104584 PMID:21138478 PMID:22798144 PMID:22970155 PMID:24010542 PMID:24033266 PMID:24916970 PMID:25682074 PMID:25741868 PMID:25940717 PMID:26295337 PMID:26467025 PMID:26845104 PMID:28324225 PMID:28492532 PMID:28541631 PMID:28692638 PMID:28724667 PMID:28993434 PMID:29310832 PMID:29335925 PMID:29360550 PMID:29752822 PMID:29907814 PMID:30093976 PMID:30287823 PMID:30613976 PMID:30702160 PMID:30720243 PMID:30720863 PMID:30736435 PMID:30875412 PMID:31159747 PMID:31214711 PMID:31360904 PMID:31396961 PMID:31589614 PMID:31742824 PMID:31825140 PMID:31957001 PMID:32072338 PMID:32295079 PMID:32338768 PMID:32846166 PMID:32959997 PMID:33471991 PMID:33558524 PMID:36988593 More...
|
|
NCBI chr 3:11,070,086...11,155,257
Ensembl chr 3:11,071,682...11,155,213
|
|
G
|
BTK
|
Bruton tyrosine kinase
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:24869598 PMID:25082755 PMID:25189416 PMID:25741868 PMID:27199251 PMID:28049639 PMID:28212557 PMID:28418267 PMID:28492532 PMID:29496671 PMID:29875397 PMID:30018078 PMID:32455989 PMID:33154951 PMID:36029036 More...
|
|
NCBI chr X:89,690,569...89,727,420
|
|
G
|
CARD11
|
caspase recruitment domain family member 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:missense mutations:exons:multiple (human)
|
CTD RGD |
PMID:18323416 PMID:25049379 PMID:26192916 |
RGD:11100036 |
|
|
G
|
CAT
|
catalase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G
|
CCDC86
|
coiled-coil domain containing 86
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23828858 |
|
NCBI chr 1:12,994,892...13,004,134
Ensembl chr 1:12,992,953...13,004,029
|
|
G
|
CD22
|
CD22 molecule
|
treatment
|
ISO
|
|
RGD |
PMID:25708834 |
RGD:151665133 |
NCBI chr 6:30,251,220...30,285,084
Ensembl chr 6:30,270,229...30,282,859
|
|
G
|
CD40
|
CD40 molecule
|
susceptibility
|
ISO
|
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human)
|
RGD |
PMID:20473910 |
RGD:5490541 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G
|
CD79A
|
CD79a molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25049379 |
|
NCBI chr 6:36,078,057...36,089,367
|
|
G
|
CD79B
|
CD79b molecule
|
treatment severity
|
ISO
|
DNA:missense mutation:multiple, exon 5 (human) ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
RGD ClinVar |
PMID:11160144 PMID:25708834 PMID:31402495 PMID:31609782 |
RGD:151665133 RGD:151665203 |
NCBI chr16:57,339,492...57,343,085
Ensembl chr16:57,339,457...57,343,358
|
|
G
|
CDK1
|
cyclin dependent kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19223503 |
|
NCBI chr 9:70,475,736...70,492,947
|
|
G
|
CHEK2
|
checkpoint kinase 2
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:16199547 PMID:21876083 PMID:24713400 PMID:28492532 |
|
NCBI chr19:11,567,529...11,621,180
Ensembl chr19:11,567,528...11,604,792
|
|
G
|
CLTC
|
clathrin heavy chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22474449 |
|
NCBI chr16:33,751,641...33,826,415
Ensembl chr16:33,752,556...33,799,102
|
|
G
|
CREBBP
|
CREB binding protein
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:24755471 PMID:28481359 PMID:30239046 PMID:33323405 |
|
NCBI chr 5:3,415,548...3,570,030
Ensembl chr 5:3,415,412...3,540,943
|
|
G
|
DICER1
|
dicer 1, ribonuclease III
|
disease_progression
|
ISO
|
|
RGD |
PMID:25195038 |
RGD:149735347 |
NCBI chr24:72,915,550...72,986,658
Ensembl chr24:72,915,499...72,963,006
|
|
G
|
DNMT3A
|
DNA methyltransferase 3 alpha
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:25363760 PMID:25741868 PMID:29900417 PMID:30478443 PMID:32581362 PMID:33238114 PMID:34315901 More...
|
|
NCBI chr14:82,313,414...82,427,170
Ensembl chr14:82,402,826...82,420,819
|
|
G
|
ETV6
|
ETS variant transcription factor 6
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:35053500 |
|
NCBI chr11:11,567,522...11,812,292
Ensembl chr11:11,567,632...11,811,716
|
|
G
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20081860 PMID:28438623 |
RGD:126779596 |
NCBI chr21:117,380,518...117,515,224
Ensembl chr21:117,380,361...117,421,573
|
|
G
|
FCGR2A
|
Fc fragment of IgG receptor IIa
|
disease_progression
|
ISO
|
DNA:SNP: :rs1801274 (human)
|
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chr20:2,480,710...2,512,429
|
|
G
|
FOXO1
|
forkhead box O1
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:26314988 PMID:29721381 PMID:35079069 |
|
NCBI chr 3:18,916,849...19,027,776
Ensembl chr 3:18,920,651...19,027,707
|
|
G
|
GLI1
|
GLI family zinc finger 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21625222 |
|
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
|
|
G
|
GSTP1
|
glutathione S-transferase pi 1
|
susceptibility
|
ISO
|
DNA:SNP: :(rs1695)(human)
|
RGD |
PMID:19338043 |
RGD:8547939 |
NCBI chr 1:6,676,897...6,679,936
|
|
G
|
ICAM1
|
intercellular adhesion molecule 1
|
disease_progression
|
ISO
|
proteion:increased expression:serum:
|
RGD |
PMID:12598355 |
RGD:11354982 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G
|
IL21R
|
interleukin 21 receptor
|
|
ISO
|
diffuse large B-cell lymphoma DNA:translocation:promoter,CDS:t(3;16)(q27;p11) results in IL21R promoter fused to BCL6 coding region
|
RGD |
PMID:11821949 |
RGD:1600111 |
NCBI chr 5:25,105,947...25,153,914
Ensembl chr 5:25,106,519...25,153,703
|
|
G
|
IMMP2L
|
inner mitochondrial membrane peptidase subunit 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27356265 |
|
NCBI chr21:79,530,113...80,388,851
|
|
G
|
IRF4
|
interferon regulatory factor 4
|
disease_progression
|
ISO
|
|
RGD |
PMID:15701085 |
RGD:11530023 |
NCBI chr17:71,739,920...71,758,811
|
|
G
|
KMT2D
|
lysine methyltransferase 2D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21804550 |
|
NCBI chr11:45,260,873...45,303,898
Ensembl chr11:45,263,408...45,302,423
|
|
G
|
LOC103224275
|
glutathione S-transferase Mu 1
|
treatment
|
ISO
|
|
RGD |
PMID:20303013 |
RGD:10450835 |
NCBI chr20:23,854,969...23,861,634
|
|
G
|
LOC103246803
|
mismatch repair endonuclease PMS2
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
|
|
NCBI chr28:15,174,359...15,209,962
Ensembl chr28:15,172,100...15,209,852
|
|
G
|
MALT1
|
MALT1 paracaspase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
NCBI chr18:20,984,985...21,064,198
Ensembl chr18:20,985,819...21,054,554
|
|
G
|
MKI67
|
marker of proliferation Ki-67
|
disease_progression
|
ISO
|
|
RGD |
PMID:20919850 |
RGD:6483541 |
NCBI chr 9:120,697,183...120,727,039
Ensembl chr 9:120,698,834...120,726,866
|
|
G
|
MTHFR
|
methylenetetrahydrofolate reductase
|
susceptibility
|
ISO
|
DNA:transition, transversion, haplotype:cds:g.677C>T, g.1298A>C (human)
|
RGD |
PMID:17712558 |
RGD:6893517 |
NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
|
|
G
|
MYC
|
MYC proto-oncogene, bHLH transcription factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27356265 |
|
NCBI chr 8:122,282,989...122,288,392
Ensembl chr 8:122,282,630...122,288,384
|
|
G
|
MYD88
|
MYD88 innate immune signal transduction adaptor
|
severity
|
ISO
|
DNA:missense mutation:L265P (human) ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
RGD ClinVar |
PMID:21179087 PMID:22931316 PMID:23215570 PMID:23355535 PMID:28492532 PMID:31609782 More...
|
RGD:151665203 |
NCBI chr15:1,276,804...1,281,811
Ensembl chr15:1,276,798...1,281,166
|
|
G
|
NBN
|
nibrin
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:9590180 PMID:16415040 PMID:28492532 |
|
NCBI chr 8:85,017,807...85,069,219
Ensembl chr 8:85,015,752...85,069,028
|
|
G
|
NECTIN2
|
nectin cell adhesion molecule 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27356265 |
|
NCBI chr 6:38,320,791...38,361,419
Ensembl chr 6:38,320,933...38,361,742
|
|
G
|
NF1
|
neurofibromin 1
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:21390130 PMID:22158541 PMID:23292937 |
|
NCBI chr16:24,550,983...24,836,311
Ensembl chr16:24,550,977...24,836,307
|
|
G
|
NFKBIA
|
NFKB inhibitor alpha
|
no_association
|
ISO
|
SNA:polymorphism(s)
|
RGD |
PMID:15198731 |
RGD:2298905 |
NCBI chr24:12,211,619...12,216,185
Ensembl chr24:12,210,281...12,214,854
|
|
G
|
NOM1
|
nucleolar protein with MIF4G domain 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22474449 |
|
NCBI chr21:125,078,090...125,098,819
|
|
G
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
|
|
G
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
NCBI chr15:10,218,034...10,304,874
Ensembl chr15:10,218,805...10,294,316
|
|
G
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
NCBI chr15:51,705,585...51,885,848
Ensembl chr15:51,775,733...51,889,238
|
|
G
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
NCBI chr20:122,040,131...122,111,397
Ensembl chr20:122,041,963...122,078,504
|
|
G
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21173233 |
|
NCBI chr21:75,781,812...75,823,404
Ensembl chr21:75,784,648...75,825,496
|
|
G
|
PRDM1
|
PR/SET domain 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:22321048 |
RGD:150530470 |
NCBI chr13:67,695,436...67,719,487
Ensembl chr13:67,695,309...67,718,931
|
|
G
|
PRDX3
|
peroxiredoxin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr 9:111,957,865...111,968,514
Ensembl chr 9:111,955,952...111,968,475
|
|
G
|
PRDX4
|
peroxiredoxin 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr X:22,113,405...22,136,307
Ensembl chr X:22,116,605...22,136,308
|
|
G
|
PRMT5
|
protein arginine methyltransferase 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:31123343 |
|
NCBI chr29:23,288,458...23,297,746
Ensembl chr29:23,288,835...23,297,518
|
|
G
|
PTEN
|
phosphatase and tensin homolog
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:9467011 PMID:10468583 PMID:10698513 PMID:10866302 PMID:10866658 PMID:11035045 PMID:12297295 PMID:17526800 PMID:17526801 PMID:21194675 PMID:21956414 PMID:22628360 PMID:24778394 PMID:24905788 PMID:25157968 PMID:25336918 PMID:25448482 PMID:25669429 PMID:25741868 PMID:26467025 PMID:28475857 PMID:28492532 PMID:28526761 PMID:29874181 PMID:35931053 More...
|
|
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
|
|
G
|
RANGAP1
|
Ran GTPase activating protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27150054 |
|
NCBI chr19:23,789,839...23,829,653
Ensembl chr19:23,788,241...23,829,631
|
|
G
|
RPS6KB1
|
ribosomal protein S6 kinase B1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19223503 |
|
NCBI chr16:33,498,098...33,556,553
Ensembl chr16:33,497,392...33,556,453
|
|
G
|
SEC31A
|
SEC31 homolog A, COPII coat complex component
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22474449 |
|
NCBI chr 7:31,207,349...31,288,484
Ensembl chr 7:31,207,089...31,288,574
|
|
G
|
SF3A1
|
splicing factor 3a subunit 1
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:22037554 PMID:26498691 PMID:33563892 |
|
NCBI chr19:13,213,059...13,237,200
Ensembl chr19:13,211,275...13,237,257
|
|
G
|
SKP2
|
S-phase kinase associated protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18850583 |
|
NCBI chr 4:35,009,114...35,040,518
Ensembl chr 4:35,009,076...35,042,632
|
|
G
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
ISO
|
|
MouseDO |
|
|
NCBI chr16:56,615,171...56,728,239
|
|
G
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:19734449 PMID:23296022 PMID:26336985 PMID:28302137 PMID:29625055 |
|
NCBI chr 5:10,731,866...10,733,745
Ensembl chr 5:10,732,350...10,732,991
|
|
G
|
SOD2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
|
|
G
|
SOD3
|
superoxide dismutase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr27:25,554,474...25,559,873
Ensembl chr27:25,555,082...25,555,804
|
|
G
|
STAT3
|
signal transducer and activator of transcription 3
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:21690253 PMID:22591296 PMID:22859607 PMID:23926297 PMID:25873174 PMID:26702067 PMID:28492532 PMID:29162862 PMID:29180260 PMID:30940614 PMID:31737384 PMID:31770611 PMID:31771617 PMID:32231398 PMID:36228738 PMID:36240433 PMID:36630607 More...
|
|
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
|
|
G
|
SYK
|
spleen associated tyrosine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33782605 |
|
NCBI chr12:101,254,085...101,374,724
Ensembl chr12:101,260,061...101,349,856
|
|
G
|
TBL1XR1
|
TBL1X/Y related 1
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:9450851 PMID:16492805 PMID:21156281 PMID:21156282 PMID:25741868 PMID:26769062 PMID:28492532 PMID:28562391 PMID:32619424 PMID:32932517 PMID:35165208 More...
|
|
NCBI chr15:12,223,404...12,406,165
Ensembl chr15:12,224,226...12,402,908
|
|
G
|
TP53
|
tumor protein p53
|
|
ISO
|
ClinVar Annotator: match by term: Diffuse large B cell lymphoma
|
ClinVar |
PMID:1631137 PMID:1978757 PMID:8062826 PMID:8099841 PMID:8425176 PMID:8527048 PMID:9150393 PMID:9242456 PMID:9598730 PMID:9825943 PMID:10089074 PMID:10414702 PMID:11051239 PMID:11782540 PMID:12826609 PMID:14743206 PMID:16818505 PMID:17417627 PMID:17427234 PMID:17606709 PMID:17881637 PMID:19378321 PMID:20013323 PMID:20128691 PMID:20182602 PMID:20407015 PMID:20522432 PMID:21059199 PMID:21343334 PMID:21519010 PMID:21601526 PMID:22186996 PMID:22265402 PMID:22713868 PMID:22915647 PMID:22955915 PMID:23172776 PMID:23246812 PMID:23667202 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24573247 PMID:24603336 PMID:24651015 PMID:25157968 PMID:25741868 PMID:25925845 PMID:25952993 PMID:26230955 PMID:26467025 PMID:26585234 PMID:26619011 PMID:26787237 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28369373 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28985567 PMID:29025599 PMID:29324801 PMID:29979965 PMID:30224644 PMID:30327374 PMID:31127191 PMID:31775759 PMID:32187361 PMID:33300245 PMID:36988593 More...
|
|
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
|
|
G
|
TXNIP
|
thioredoxin interacting protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16081686 |
|
NCBI chr20:12,756,145...12,759,853
Ensembl chr20:12,756,053...12,761,177
|
|